शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
CINELINENSECINELINE INDIA LIMITED· EntertainmentMediumNeutral
Announced Mon, 2 Nov, 2026 · 23:08 IST

Q2 FY27 investor presentation shows revenue growth and expansion pipeline

CINELINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.7%Reaction day
₹91.80
prior close
₹92.85
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-2.0% vs market
Film Production Distribution & Exhibition peers, median of 5sector-0.2%-1.5% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.5 pts less than its Film Production Distribution & Exhibition peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.7
10m
-1.1
15m
-1.5
30m
-1.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.7+0.3-2.0-0.2-1.5
Next day
-2.6+2.4-5.0-0.5-2.0
2d
-3.6+3.6-7.2+0.8-4.4
3d
-5.4pendingpending+2.8-8.2
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Film Production Distribution & Exhibition peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Cineline India reported its highest-ever quarterly revenue of Rs 7,566 lakh for Q2 FY27, up 18% year on year, with profit after tax of Rs 726 lakh. H1 FY27 revenue rose 22% to Rs 13,597 lakh. The network has 86 operating screens, and 35 committed screens are planned, with 20-25 targeted to open in FY27.

Likely market impact

Positive for the stock as revenue, profit and expansion visibility improved, though new screen openings remain subject to licences and approvals.